TY - JOUR AU - Liu, Q. AU - Sun, J. D. AU - Wang, J. PY - 2012 DA - 2012// TI - TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules JO - Cancer Chemother Pharmacol VL - 69 UR - https://doi.org/10.1007/s00280-012-1852-8 DO - 10.1007/s00280-012-1852-8 ID - Liu2012 ER - TY - JOUR AU - Sun, J. D. AU - Liu, Q. AU - Wang, J. PY - 2012 DA - 2012// TI - Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-1980 DO - 10.1158/1078-0432.CCR-11-1980 ID - Sun2012 ER - TY - JOUR AU - VanCutsem, E. AU - Lenz, H. -. J. AU - Furuse, J. PY - 2016 DA - 2016// TI - Evofosfamide (TH-302) in combination with gemcitabine in previously untreated patients with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma: primary analysis of the randomized, double-blind phase III MAESTRO study JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/jco.2016.34.4_suppl.193 DO - 10.1200/jco.2016.34.4_suppl.193 ID - VanCutsem2016 ER - TY - JOUR AU - Koong, A. C. AU - Mehta, V. K. AU - Le, Q. T. PY - 2000 DA - 2000// TI - Pancreatic tumors show high levels of hypoxia JO - Int J Radiat Oncol Biol Phys VL - 48 UR - https://doi.org/10.1016/S0360-3016(00)00803-8 DO - 10.1016/S0360-3016(00)00803-8 ID - Koong2000 ER - TY - JOUR AU - Klaassen, R. AU - Bennink, R. J. AU - van Tienhoven, G. PY - 2015 DA - 2015// TI - Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer JO - Radiother Oncol VL - 116 UR - https://doi.org/10.1016/j.radonc.2015.05.009 DO - 10.1016/j.radonc.2015.05.009 ID - Klaassen2015 ER - TY - JOUR AU - Metran-Nascente, C. AU - Yeung, I. AU - Vines, D. C. PY - 2016 DA - 2016// TI - Measurement of tumor hypoxia in patients with advanced pancreatic cancer based on 18F-fluoroazomyin arabinoside uptake JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.167650 DO - 10.2967/jnumed.115.167650 ID - Metran-Nascente2016 ER - TY - JOUR AU - Segard, T. AU - Robins, P. D. AU - Yusoff, I. F. PY - 2013 DA - 2013// TI - Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer JO - Clin Nucl Med VL - 38 UR - https://doi.org/10.1097/RLU.0b013e3182708777 DO - 10.1097/RLU.0b013e3182708777 ID - Segard2013 ER - TY - JOUR AU - Russell, J. AU - Carlin, S. AU - Burke, S. A. AU - Wen, B. AU - Yang, K. M. AU - Ling, C. C. PY - 2009 DA - 2009// TI - Immunohistochemical detection of changes in tumor hypoxia JO - Int J Radiat Oncol Biol Phys VL - 73 UR - https://doi.org/10.1016/j.ijrobp.2008.12.004 DO - 10.1016/j.ijrobp.2008.12.004 ID - Russell2009 ER - TY - JOUR AU - Grierson, J. R. AU - Link, J. M. AU - Mathis, C. A. AU - Rasey, J. S. AU - Krohn, K. A. PY - 1989 DA - 1989// TI - A radiosynthesis of fluorine-18 fluoromisonidazole JO - J Nucl Med VL - 30 ID - Grierson1989 ER - TY - JOUR AU - Russell, J. AU - Pillarsetty, N. AU - Kramer, R. M. PY - 2017 DA - 2017// TI - In vitro and in vivo comparison of gemcitabine and the gemcitabine analog 1-(2′-deoxy-2′-fluoroarabinofuranosyl) cytosine (FAC) in human orthotopic and genetically modified mouse pancreatic cancer models JO - Mol Imaging Biol VL - 19 UR - https://doi.org/10.1007/s11307-017-1078-6 DO - 10.1007/s11307-017-1078-6 ID - Russell2017 ER - TY - JOUR AU - Rischin, D. AU - Hicks, R. J. AU - Fisher, R. PY - 2006 DA - 2006// TI - Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02 JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.05.2878 DO - 10.1200/JCO.2005.05.2878 ID - Rischin2006 ER -